Thomas Crellen
I'm a postgraduate researcher working in the Bacterial Resistance Analysis Group in the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. My project focusses on determining risk factors for acquisition of drug resistant bacteria among neonates in a Cambodian hospital. The main organism in both carriage and blood stream infections was Klebsiella pneumoniae, we have sequenced over 300 isolates and aim to use the whole genome data to reconstruct transmission networks within the ward.
Prior to starting at MORU I worked as a field epidemiologist for Médecins Sans Frontières in the Central African Republic and the Democratic Republic of Congo.
My PhD was at Imperial College London and the Wellcome Trust Sanger Institute, focussing on the genomics and epidemiology of Schistosoma mansoni, a neglected tropical disease.
Recent publications
-
Natural history of a parasite-induced biliary cancer
Crellen T. et al, (2024)
-
Diagnostic value of urinary and serum IgG antibodies in evaluating drug treatment response in strongyloidiasis assessed by fecal examination and digital droplet PCR.
Wongphutorn P. et al, (2024), PloS one, 19
-
Modelling morbidity for neglected tropical diseases: the long and winding road from cumulative exposure to long-term pathology
Borlase A. et al, (2023), Philosophical Transactions of the Royal Society B: Biological Sciences, 378
-
Diagnostic performance of Strongyloides-specific IgG4 detection in urine for diagnosis of human strongyloidiasis
Wongphutorn P. et al, (2023), Parasites & Vectors, 16
-
Comparison of a Urine Antigen Assay and Multiple Examinations with the Formalin-Ethyl Acetate Concentration Technique for Diagnosis of Opisthorchiasis
Worasith C. et al, (2023), The American Journal of Tropical Medicine and Hygiene, 109, 159 - 165